6505--Carbidopa Levodopa Immediate Release (IR) Tablets

Amendment / Modification

• The deadline for the receipt of offers has been extended.

• The original deadline was January 27, 2026.

• The new deadline is February 3, 2026, at 2:30 PM Central Time.

• Solicitation Number: 36E79726R0008

• The hour and date specified for receipt of offers is extended to February 3, 2026, 2:30 PM CST.

• All other terms and conditions of the original solicitation remain unchanged.

Solicitation / RFP / RFQ

This solicitation seeks proposals for the supply of Carbidopa/Levodopa Immediate-Release (IR) Tablets to the Department of Veterans Affairs (VA) and Department of Defense (DoD) Pharmaceutical Prime Vendor (PPV) Programs. The objective is to establish a supply source for these essential medications to ensure nationwide availability and consistent product for government healthcare facilities.

• Products: Carbidopa/Levodopa IR Tablets in various strengths and package sizes (100, 500, 1000 tablets per bottle).

• Pricing: Offerors must submit prices for the base year and all four option years for all line items. Prices must not exceed two decimal places and must include a 0.5% Cost Recovery Fee.

• NDC Number: Offerors must provide a unique 11-digit National Drug Code (NDC) number for each offered drug, specific to the offeror's company.

• Manufacturer Information: Offerors not manufacturing the items must submit a Letter of Commitment from the manufacturer.

• Packaging: Must meet specific requirements including safety caps (for bottles <= 400 tablets), compatibility with automated dispensing units, and no glass bottles.

• Barcoding: All pharmaceutical products must include GS1-128 or HIBCC compliant bar code labeling at the unit-of-use package level.

• DSCSA Compliance: Adherence to Drug Supply Chain Security Act (DSCSA) requirements for serialized transaction information and transaction statements.

• cGMP Compliance: Manufacturing facilities must have an acceptable current Good Manufacturing Practices (cGMP) status on record with the FDA.

• Contract Type: Firm Fixed Price, Indefinite-Delivery Requirements contract.

• Period of Performance: Base year plus four one-year option periods.

• Distribution: Products will be distributed through Government Prime Vendor contract(s) (McKesson, Cencora, Cardinal Health, DMS Pharmaceutical Group).

• Submission Method: Proposals must be submitted via email to Raymond.roldan@va.gov and Nicholas.mcgregor@va.gov as Microsoft Word or PDF files, including a scanned PDF of the signed SF-1449. Faxed proposals are not acceptable.

• Offer Due Date: January 27, 2026, 2:30 PM Local Time.

• Evaluation: Award will be made to the responsible offeror with the lowest price technically acceptable offer. Technical acceptability includes meeting product descriptions, NDC requirements, FDA approval, FDA cGMP compliance, and manufacturing facility clearance.

• Pricing Evaluation: Computed by multiplying estimated quantity by unit price for base and option years across all line items.

• NAICS Code: 325412 (Pharmaceutical Preparation Manufacturing)

• Size Standard: 1300 Employees.

• Small Business Subcontracting Plan: Required for other than small business concerns for contracts over $900,000.

• Offerors must price for the base year and all four option years for all line items to be considered for award.

• Prices offered shall not exceed two decimal places.

• A 0.5% Cost Recovery Fee is included in offered prices.

• Offerors must maintain the same manufacturer (NDA/ANDA/BLA) for the duration of the contract unless approved otherwise by the Contracting Officer.

• The solicitation incorporates by reference numerous FAR and VAAR clauses.

Solicitation / RFP / RFQ

This is a pre-solicitation notice for Request for Proposal (RFP) 36E79726R0008, an unrestricted procurement for Carbidopa Levodopa Immediate Release (IR) Tablets. The Department of Veterans Affairs (VA) National Acquisition Center intends to award one contract to a responsible offeror capable of providing an uninterrupted supply. The contract will serve the VA (including Consolidated Mail Order Pharmacies and State Veterans Homes), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC).

• Supply of Carbidopa Levodopa Immediate Release (IR) Tablets.

• Offerors must specify the exact drug name (as it appears on the label) and possess a unique NDC number for the supplied drug.

• The successful offeror's label and unique NDC will be the sole labeling for the product.

• Contract type: Commercial item format (FAR Part 12).

• Contract period: One year with four pre-priced one-year option periods.

• Distribution: Through VA's and DoD's respective Pharmaceutical Prime Vendor Programs.

• Solicitation will be electronically issued on or about December 18, 2025.

• Tentative closing date: January 8, 2026, 2:30 PM Central Time, Chicago, USA.

• No paper copies of the solicitation will be available.

• Interested offerors should continuously check SAM.gov for updates.

• All responsible sources may submit an offer.

• Unrestricted procurement.

• NAICS Code: 325412.

• Estimated annual requirements for various tablet strengths and package sizes are provided in the document.

• Point of Contact: Ray Roldan, Contract Specialist, Raymond.Roldan@va.gov, 708-786-4930.